Discriminant Score for Diagnosing Advanced Fibrosis or Cirrhosis

Objective: The aim of the study was to assess the utility of a modified three-parameter cirrhosis discriminant score (CDS) for diagnosing advanced fibrosis or cirrhosis in patients with evidence of chronic hepatitis C, Methods: We examined liver tissue from 79 patients, Patients with a histological fibrosis score of 0-2 made up group A, and patients with a score of 3 or 4 (advanced fibrosis or cirrhosis) group B.

Results: The modified CDS (possible total score 0-11) was derived from three laboratory parameters: platelets, ALT/AST ratio, and PT, The total score was significantly lower in group A (4.3 +/- 2.0) than in group B (7.9 +/- 1.4) (p < 0.0001), There was a positive correlation between the CDS and histological fibrosis score (r = 0,64,p < 0.0001), With 8 or above as the cutoff value, the CDS had a sensitivity of 46% and a specificity of 98 % for the diagnosis of histological fibrosis scores of 3 or 4.

Conclusions: We conclude that a three-parameter CDS is useful for identifying patients with hepatitis C and a high likelihood of cirrhosis, Patients with a CDS less than or equal to 7 still require histological examination to identify advanced fibrosis or cirrhosis.

Author: BONACINI M, UNIV SO CALIF, RANCHO LOS AMIGOS MED CTR, LIVER UNIT, BLDG 500, 7601 E IMPERIAL HIGHWAY DOWNEY, CA 90242
Source: AMERICAN JOURNAL OF GASTROENTEROLOGY 1997 AUG;92(8):1302-1304

Advertisement

Hepatitis C Primer Home

What is Hepatitis How is Hepatitis Transmitted

Long-term Prognosis

Complications of HCV Liver Biopsy Treatment Info (Interferon, Herbal, etc) Lab Tests (PCR, Genotype,etc.) Nutrition & Alternative Info

Patient Information (Support Groups, Doctor Listing, etc) Related Webpages Transplant Info Site Search HCV Webrings Guestbook FAQ & Disclaimers

Early Treatment Magnifies Success Against HCV
While the currently approved treatment for chronic Hepatitis C is about 50 percent effective, new research from Canada claims that early treatment boosts its effectiveness up to 90 percent....

Popular Blood Thinner May Reduce Liver Scarring
Successful animal studies have paved the way for a human trial to determine if warfarin prevents liver damage in those with Hepatitis C....

R1626 Could Help Defeat Hepatitis C
Whether added to standard combination therapy or as a monotherapy, studies show that R1626 is a powerful HCV anti-viral medicine....

More Hep C articles ...